Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cycle Pharmaceuticals Selects LeMed as Exclusive U.S. Distribution & Services Partner for HARLIKU | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Cycle Pharmaceuticals Selects LeMed as Exclusive U.S. Distribution & Services Partner for HARLIKU

LeMed will manage commercial and non-commercial dispensing for HARLIKU across the United States.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Cycle Pharmaceuticals has awarded LeMed Specialty Pharmacy the exclusive contract for specialty pharmacy distribution and services for HARLIKU (nitisinone) Tablets, the first and only FDA-approved treatment for use in alkaptonuria (AKU).

LeMed will manage commercial and non-commercial dispensing for HARLIKU across the United States.

“We’re excited to extend our partnership with LeMed Specialty Pharmacy, building on years of successful collaboration across rare diseases. Together, we remain dedicated to putting patients first— ensuring those living with AKU receive the support and treatment they need, now and into the future,” said Chikai Lai, SVP & CCO, Cycle Pharmaceuticals

“We are honored Cycle chose LeMed to ensure every eligible AKU patient gets timely access to HARLIKU,” said Nathaniel Keifer, Vice President, Client Strategy at LeMed Specialty Pharmacy. “Our one-size-fits-one bespoke model pairs clinical excellence and a patient-experience mindset with real-time data insights and an agile infrastructure, enabling Cycle to monitor outcomes and scale when necessary while patients experience the speed to therapy and support they deserve.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters